BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23716302)

  • 1. Multistep continuous-flow synthesis in medicinal chemistry: discovery and preliminary structure-activity relationships of CCR8 ligands.
    Petersen TP; Mirsharghi S; Rummel PC; Thiele S; Rosenkilde MM; Ritzén A; Ulven T
    Chemistry; 2013 Jul; 19(28):9343-50. PubMed ID: 23716302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multistep continuous-flow system for rapid on-demand synthesis of receptor ligands.
    Petersen TP; Ritzén A; Ulven T
    Org Lett; 2009 Nov; 11(22):5134-7. PubMed ID: 19852497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
    Jensen PC; Thiele S; Steen A; Elder A; Kolbeck R; Ghosh S; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2012 May; 166(1):258-75. PubMed ID: 22050085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
    Rummel PC; Arfelt KN; Baumann L; Jenkins TJ; Thiele S; Lüttichau HR; Johnsen A; Pease J; Ghosh S; Kolbeck R; Rosenkilde MM
    Br J Pharmacol; 2012 Nov; 167(6):1206-17. PubMed ID: 22708643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships and identification of optmized CC-chemokine receptor CCR1, 5, and 8 metal-ion chelators.
    Chalikiopoulos A; Thiele S; Malmgaard-Clausen M; Rydberg P; Isberg V; Ulven T; Frimurer TM; Rosenkilde MM; Gloriam DE
    J Chem Inf Model; 2013 Nov; 53(11):2863-73. PubMed ID: 24083637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.
    Barington L; Rummel PC; Lückmann M; Pihl H; Larsen O; Daugvilaite V; Johnsen AH; Frimurer TM; Karlshøj S; Rosenkilde MM
    J Biol Chem; 2016 Jul; 291(31):16208-20. PubMed ID: 27226537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.
    Liu L; Doijen J; D'huys T; Verhaegen Y; Dehaen W; De Jonghe S; Schols D; Van Loy T
    Biochem Pharmacol; 2021 Jun; 188():114565. PubMed ID: 33872569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8.
    Jenkins TJ; Guan B; Dai M; Li G; Lightburn TE; Huang S; Freeze BS; Burdi DF; Jacutin-Porte S; Bennett R; Chen W; Minor C; Ghosh S; Blackburn C; Gigstad KM; Jones M; Kolbeck R; Yin W; Smith S; Cardillo D; Ocain TD; Harriman GC
    J Med Chem; 2007 Feb; 50(3):566-84. PubMed ID: 17266208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
    Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
    Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 8. Activation mechanisms of chemokine receptors.
    Jensen PC; Rosenkilde MM
    Methods Enzymol; 2009; 461():171-90. PubMed ID: 19480919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Frecentese F; Massarelli P; Bruni G; Collavoli E; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2008 Jan; 341(1):20-7. PubMed ID: 18072244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palladium-catalyzed cross-coupling reactions on a bromo-naphthalene scaffold in the search for novel human CC chemokine receptor 8 (CCR8) antagonists.
    Verhaegen Y; Liu L; Nguyen TT; Van Loy T; Voet ARD; Schols D; Dehaen W; De Jonghe S
    Bioorg Chem; 2021 Feb; 107():104560. PubMed ID: 33383325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.
    Fiorino F; Magli E; Perissutti E; Severino B; Frecentese F; Esposito A; De Angelis F; Incisivo GM; Massarelli P; Nencini C; Di Gennaro E; Budillon A; Di Cintio A; Santagada V; Caliendo G
    Eur J Med Chem; 2011 Jun; 46(6):2206-16. PubMed ID: 21440338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8.
    Haskell CA; Horuk R; Liang M; Rosser M; Dunning L; Islam I; Kremer L; Gutiérrez J; Marquez G; Martinez-A C; Biscone MJ; Doms RW; Ribeiro S
    Mol Pharmacol; 2006 Jan; 69(1):309-16. PubMed ID: 16221874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
    Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of the first nonpeptidergic inverse agonists for the human cytomegalovirus encoded chemokine receptor US28.
    Hulshof JW; Casarosa P; Menge WM; Kuusisto LM; van der Goot H; Smit MJ; de Esch IJ; Leurs R
    J Med Chem; 2005 Oct; 48(20):6461-71. PubMed ID: 16190772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8.
    Jiang S; Lin X; Wu L; Wang L; Wu Y; Xu Z; Xu F
    Sci Adv; 2024 Feb; 10(5):eadj7500. PubMed ID: 38306437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
    Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
    Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.